Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

5.6%

6 terminated/withdrawn out of 108 trials

Success Rate

92.0%

+5.5% vs industry average

Late-Stage Pipeline

7%

8 trials in Phase 3/4

Results Transparency

0%

0 of 69 completed trials have results

Key Signals

6 recruiting

Enrollment Performance

Analytics

N/A
27(60.0%)
Phase 2
7(15.6%)
Phase 4
4(8.9%)
Phase 3
4(8.9%)
Phase 1
2(4.4%)
Early Phase 1
1(2.2%)
45Total
N/A(27)
Phase 2(7)
Phase 4(4)
Phase 3(4)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (108)

Showing 20 of 108 trials
NCT01410045Not ApplicableActive Not Recruiting

Cryopreservation of Ovarian Cortex in Girls With Turner Syndrome

Role: collaborator

NCT06199284Not ApplicableSuspended

Atalante Exoskeleton in the Rehabilitation of Patients With Amyotrophic Lateral Sclerosis

Role: collaborator

NCT07315685Not ApplicableNot Yet Recruiting

Understanding and Treating Severe and Resistant Pathological Aggression: Using Deep Brain Stimulation to Treat Resistant Aggression

Role: collaborator

NCT01373710Phase 1Completed

Intrathecal Trastuzumab Administration in Metastatic Breast Cancer Patients Developing Carcinomatous Meningitis

Role: collaborator

NCT07163689Recruiting

TIPS for Complicated Portal Hypertension Related to Porto-Sinusoidal Vascular Disease

Role: collaborator

NCT06876064Not Yet Recruiting

National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

Role: collaborator

NCT00937807Phase 4Completed

Hemodynamic Stability During Carotid Endarterectomy.Comparison of LENOXe™ (Xenon 100% v/v) Versus Sevoflurane

Role: collaborator

NCT03905239Not ApplicableRecruiting

A Procalcitonin-based Algorithm in Adhesion-related Small Bowel Obstruction

Role: collaborator

NCT06955624Not ApplicableRecruiting

Use of Omics Methods to Classify Variations of Uncertain Significance and Improve Diagnosis of Neurogenetic Diseases

Role: collaborator

NCT03184662Not ApplicableTerminated

Efficacy of a High-intensity Physical Activity Program on Renal Function in High Risk Patients With Type 2 Diabetes

Role: collaborator

NCT06739239Recruiting

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Role: collaborator

NCT02907554Phase 4Completed

Cyclosporine a Pretreatment and Kidney Graft Function

Role: collaborator

NCT06720571Not ApplicableRecruiting

Effects of Transcutaneous Vagus Nerve Stimulation on Emotion Regulation and Executive Functioning in Prader-Willi Syndrome

Role: collaborator

NCT06515678Active Not Recruiting

Impact of Antihypertensive Therapy on Recurrence Risk of Ovarian Cancer for Bevacizumab-associated Hypertension

Role: lead

NCT06450080Not ApplicableRecruiting

Study of the Relationship Between Clinical, Imaging and Biological Data in Patients With Squamous Cell Carcinoma of the Tongue

Role: collaborator

NCT04637672Completed

Clinical Database and Biobank of Patients With Inflammatory Myopathies: the MASC Project (Myositis, DNA, Serum, Cells) (MASC)

Role: lead

NCT02112435Not ApplicableCompleted

Comparative Efficacy Study of Titratable Versus Active Mandibular Advancement Splint in Sleep Apnea

Role: collaborator

NCT05934214Completed

EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database

Role: lead

NCT02780492Completed

Outcome Measures in Duchenne Muscular Dystrophy: A Natural History Study

Role: collaborator

NCT03498066Phase 4Completed

Beta Blocker Interruption After Uncomplicated Myocardial Infarction

Role: collaborator